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Purpose: To compare bleb survival and histology after implantation of the EX-PRESS™ glaucoma filtration device versus
silicone tubes in a rabbit model of filtration surgery.
Methods: Glaucoma filtration surgery was performed on one eye each of twelve New Zealand white rabbits. Eyes were
randomized to implantation with the EX-PRESS™ filtration device (n=6) or a silicone tube (n=6). Bleb vascularity was
evaluated at three and six weeks using a standard scale. At 6 weeks, eyes were enucleated and a histologic analysis was
performed. Bleb survival was also recorded for the two groups.
Results: Histologically, a thin capsule consisting of mild fibroblast proliferation associated with intercellular collagen
was present around both implants. Both groups demonstrated a mild infiltration of plasma cells and polymorphonuclear
leukocytes. Bleb vascularity was similar between both groups at three and six weeks post-operatively. Bleb survival
between the two groups was not significantly different.
Conclusions: Similar outcomes were noted after glaucoma filtration surgery using either silicone tubes or the EX-
PRESS™ glaucoma filtration device in this rabbit model. Both implants appear to be relatively inert with little difference
in biocompatibility and bleb survival.
Glaucoma is the second leading cause of blindness world-
wide and is predicted to affect 79.6 million people by 2020
[1].  Glaucoma  filtration  surgery  is  commonly  performed
when other modalities, such as topical medications and laser
trabeculoplasty, have failed to control intraocular pressure
(IOP).  Traditional  implantable  aqueous  humor  drainage
devices, such as the Baerveldt implant and Ahmed valve, were
subsequently introduced in an effort to improve fluid outflow
and offer an alternative to traditional filtration surgery. The
EX-PRESS™ glaucoma filtration device (Alcon, Ft. Worth
TX), which differs from traditional drainage devices by the
lack of an associated end-plate, is an implantable device that
is nonvalved and made of medical grade stainless steel. It was
initially designed for full thickness scleral implantation, but
this method led to sub-optimal results. The surgical technique
was later modified so that devices are now implanted under a
partial-thickness scleral flap to provide enhanced regulation
of fluid flow [2].
Published  studies  have  shown  similar  IOP-lowering
efficacy with use of the EX-PRESS™ device compared to
traditional guarded trabeculectomy [3,4]. In addition, the EX-
PRESS™ device has also been shown to have lower rates of
hypotony  and  post-operative  complications  compared  to
traditional trabeculectomy in some studies [3]. Quicker visual
recovery and less post-operative visits were noted in one study
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in favor of the EX-PRESS™ device when compared to a
cohort of patients undergoing trabeculectomy [4].
Despite the building evidence for the surgical utility of
the EX-PRESS™ device in some patient populations, little is
known about its biocompatibility and how the presence of the
stainless steel device influences bleb morphology and local
fibrosis [4-7]. The rabbit model for trabeculectomy surgery,
which  commonly  utilizes  a  silicone  tube,  has  been  used
extensively to characterize the in vivo response of the eye to
various glaucoma implants as well as for the evaluation of
different wound modulation agents [8,9]. In the current study,
we compare bleb survival, bleb vascularity and local tissue
response after implantation of the EX-PRESS™ glaucoma
filtration device versus implanted silicone tubes in a rabbit
model of filtration surgery.
METHODS
Study design: All procedures were performed in accordance
with  The  Association  for  Research  in  Vision  and
Ophthalmology  Statement  for  the  Use  of  Animals  in
Ophthalmic and Vision Research. Twelve New Zealand white
rabbits were divided into two groups: filtration surgery with
silicone tube implantation (n=6) and filtration surgery with
the EX-PRESS™ miniature glaucoma implant. All surgeries
were performed by a single surgeon (M.Y.K.) experienced in
animal-based ophthalmic surgery.
Glaucoma  filtering  surgery  technique:  The  rabbits  were
anesthesized using intramuscular injections of ketamine and
xylazine (ketamine 40 mg/kg; xylazine 20 mg/kg) as well as
topical  anesthesia  (2%  lidocaine  gel)  before  initiation  of
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10surgery. For the implantation of the silicone drainage device,
a fornix based-conjunctival dissection was performed and a
23-gauge  needle  was  used  to  create  a  scleral  tunnel  one
millimeter posterior to the limbus for insertion of a 22-gauge
cannula (Insyte®; Becton Dickinson Vascular Access, Sandy,
UT) into the anterior chamber. The tube was then secured to
the  scleral  bed  with  10–0  nylon  suture  (Ethicon  Inc.,
Somerville, NJ) and efflux of fluid into the subconjunctival
space  was  confirmed.  For  insertion  of  the  EX-PRESS™
miniature glaucoma implant, a partial-thickness scleral flap
was created at the limbus and the implant was inserted through
a tract into the anterior chamber created by a 27-gauge needle.
Mitomycin-C (MMC) was applied to all eyes following the
conjunctival  dissection.  Two  3×3  mm  partial-thickness
Weck-cel® spears (Alcon Surgical, Fort Worth, TX) soaked
in 0.4 mg/ml MMC were placed over the scleral bed for 5 min
before insertion of the cannula or needle. The scleral bed was
then irrigated with 40 ml of balanced salt solution (BSS) after
removing  the  soaked  spears.  Topical  moxifloxacin  0.5%
(Vigamox®;  Alcon)  and  prednisolone  acetate  1%
(Predforte®, Allergan, Irvine, CA) were each instilled four
times per day for seven days following surgery in all eyes.
Post-operative  evaluation:  Daily  handheld  slit  lamp
examinations were conducted to document any changes at the
surgical  site  as  well  as  to  perform  bleb  vascularity
assessments. Bleb survival was the main outcome measure
and defined as the presence of an elevated subconjunctival
fluid pocket at the surgical site during slit lamp exam. Central
bleb  vascularity  was  graded  at  three  and  six  weeks  post-
operatively using a standard scale as noted in Table 1. Anterior
segment photographs were obtained weekly at the slit lamp in
each  eye.  A  masked  independent  investigator  objectively
graded each bleb using slit lamp photographs. All photos were
cropped before evaluation of vascularity so that the masked
evaluator could not identify which type of tube was in the
anterior  chamber.  Final  vascularity  grading  was  based  on
photos and not slit lamp exams similar to the method used for
the  Moorfields  Bleb  Grading  System.  Bleb  survival
determination was based on slit lamp exam as photos are not
ideal for determining bleb height.
Histology: All animals were euthanized at the end of the six-
week study. All eyes were then enucleated and immediately
immersed in a mixture of 4% paraformaldehyde and 2.5%
neutral  buffered  formalin  for  24  h.  The  globes  were
dehydrated, embedded in paraffin and sent for microtome
sectioning and staining (Hematoxylin and Eosin and Masson
Trichrome;  Sigma,  St.  Louis,  MO).  A  modified  semi-
quantitative grading system to assess cellularity and collagen
deposition was used to compare findings between the two
groups (Table 2) [10]. Goblet cell number was calculated
using the average cell number per high-powered field from
six consecutive central bleb cross-sections of each specimen.
A prior study has established that normal rabbit conjunctiva
typically has about seven goblet cells per high-powered field
[11]. A masked evaluation was then performed on all samples.
Statistical  analysis  using  one-way  ANOVA  test  was
completed for all data sets. A p-value <0.05 was considered
statistically significant.
RESULTS
Histologically, a thin capsule consisting of mild fibroblast
proliferation  associated  with  intercellular  collagen  was
present around both implants. Within the area surrounding
both  implants,  a  mild  infiltration  of  plasma  cells  and
polymorphonuclear  leukocytes  was  seen.  The  blebs
surrounding  both  materials  were  slightly  avascular.  Both
TABLE 1. MEAN POST-OPERATIVE VASCULARITY OF ALL GROUPS AFTER THREE AND SIX WEEKS OF FOLLOW-UP.
Group (n=6 each) Three weeks – (SD) Six weeks – (SD)
Silicone 1.33 (0.95)* 1.55 (1.03)**
EX-PRESS™ 1.72 (0.81)* 1.43 (1.72)**
        SD=Standard Deviation. *p value of vascularity differences at 3 weeks=0.462. **p value of vascularity differences at 6
        weeks=0.886.  Grading  scale  of  central  bleb  vascularity:  0=avascular  (>50%  avascularity),  1=reduced  vascularity  (<50%
        avascular), 2=normal vascularity, 3=increased vascularity (<50% increased vascularity), 4=hypervascularity (>50% increased
        vascularity).
TABLE 2. A COMPARISON OF BLEB HISTOLOGY BETWEEN GROUPS.
Group (n=6 each) Collagen deposition
(Masson trichrome)
Cellularity (H&E) Mean goblet cell number
(SD)
Silicone +/− +/− 1.29 (0.53)*
EX-PRESS™ +/− +/− 1.15 (0.91)*
        *p value for goblet cells between groups p=0.751. -=absent; +/−=weakly present; +,++,+++=present. H&E=Hematoxylin and
        Eosin. SD=Standard Deviation.
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11groups were noted to have decreased numbers of goblet cells
per high powered field but there was no significant difference
between  the  two  groups  (p=0.751).  No  differences  in  the
capsule composition or inflammatory reaction were noted
between  the  two  groups  (Table  2).  Bleb  vascularity  was
similar between both groups at the 3 and 6 week evaluation
times (Table 1).
Post-operative bleb survival was similar between the two
study groups (Table 3). The average bleb survival for rabbits
implanted with the silicone drainage device was 34.30±2.21
days.  Rabbits  implanted  with  the  EX-PRESS™  miniature
glaucoma implant had an average bleb survival of 32.15±4.32
days.  This  difference  was  not  statistically  significant
(p=0.303).
None  of  the  EX-PRESS™  devices  or  the  22-gauge
cannula were noted to be occluded by tissue at final gross and
histological examinations. There were no documented cases
of  implant  extrusion,  endophthalmitis,  corneal  epithelial
toxicity, or persistent anterior chamber inflammation in all
treated eyes.
DISCUSSION
Scar formation and fibrosis leading to bleb failure remains a
common cause of surgical failure after both trabeculectomy
and glaucoma drainage device implantation. Previous studies
investigating the histocompatibility of different biomaterials
have demonstrated a variable degree of inflammation and
fibrosis [5-8,12-14]. In theory, an ideal drainage device would
consist of an inert biomaterial with similar or better IOP-
lowering capability compared to devices currently in use. The
current study compared the histocompatibility of a silicone
drainage  device,  a  material  commonly  used  for  aqueous
drainage devices, and the EX-PRESS™ glaucoma filtration
device.  Thin  fibrotic  capsules  with  intercellular  collagen
formation and variable amounts of inflammatory cells were
noted surrounding both implants. There were no significant
differences in biocompatibility between the two materials.
A  previously  published  study  looked  at  the
biocompatibility of the EX-PRESS™ device in rabbits. The
local tissue reaction at three and six months showed a thin,
fibrotic capsule covering approximately 25% of the implant
surface area. The capsule and lumen of the device showed no
evidence of inflammation [5]. These results are comparable
to the histologic findings of our study. However, this study
had several limitations including; 1) Antifibrotic agents were
not used at the time of surgery 2) The protocol did not include
use of a scleral flap for EX-PRESS™ implantation which is
now a standard procedure and 3) The conjunctiva was not
sutured at the conclusion of surgery and the authors did not
use post-operative drops as is typical of modern day filtration
surgery. These limitations were addressed in the current study
and allow for a direct comparison of in vivo findings in a way
that is more in line with modern day use of the EX-PRESS™
device.
The histopathology of the EX-PRESS™ shunt has also
been studied after implantation in human eyes [6,7]. Aziz et
al.  [6]  reported  on  the  histopathologic  features  of  an
enucleated  eye  in  an  eighty-six  year-old  male  who  had
previously  undergone  EX-PRESS™  implantation  for
neovascular  glaucoma.  Examination  revealed  minimal
cellular reaction surrounding the implant. A thin fibrocellular
tissue layer was present beneath the implant without evidence
of  granulomatous  inflammation  or  marked  cellular
inflammatory infiltrate. De Feo et al. [7] looked at the tissue
reaction surrounding the EX-PRESS™ implant in a seventy-
three year-old female diagnosed with uncontrolled primary
open-angle glaucoma. They found a small shoulder of fibrous
tissue  between  the  spur  and  flange  of  the  device.  The
remainder of the device was covered by a thin, fibrous capsule,
but no inflammatory cells were found within the capsule.
Prior  studies  evaluating  the  biocompatibility  of
implanted  materials  have  demonstrated  a  more  intense
inflammatory reaction compared to our findings and others.
Ayyala  et  al.  [8]  looked  at  the  inflammatory  reaction
associated with the Ahmed polypropylene device compared
to  the  Baerveldt  silicone  device  in  a  rabbit  model.
Inflammatory cells were found in the fibrous capsule of both
implants. The Baerveldt silicone device was associated with
a  lower  amount  of  inflammation  compared  to  the
polypropylene version of the Ahmed valve. A follow-up study
demonstrated that the polypropylene of the Molteno device
was more inflammatory than the Krupin silicone device [12].
Histopathologic  evaluation  revealed  a  fibrous  capsule
containing inflammatory cells surrounding both biomaterials
with the Molteno polypropylene demonstrating a higher grade
of inflammation and fibrosis.
Our study does provide useful information regarding the
histocompatibility of silicone versus the stainless steel of the
EX-PRESS™ however there are some limitations. First, this
study was performed in a well established rabbit filtration
TABLE 3. A COMPARISON OF POST-OPERATIVE BLEB SURVIVAL BETWEEN GROUPS.
Group (n=6 each) Bleb survival days (SD)
Silicone tube 34.30 (2.21)*
EX-PRESS™ 32.15 (4.32)*
          *p value of bleb survival between groups=0.303. SD=Standard Deviation.
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12surgery model and the results may not directly correlate with
findings in humans [5,8,12,13]. Second, we did not include a
control  group  without  MMC  application  to  evaluate  the
influence of the antifibrotic agent or its potential alteration of
effect from the material itself. The use of MMC in this rabbit
model of glaucoma filtration surgery can lead to loss of goblet
cells,  a  decrease  in  fibroblast  proliferation  as  well  as  a
significant increase in bleb survival. For this reason, the same
dose of MMC was used in both groups to remove any potential
for confounding variables. The study was designed to closely
simulate current day practice, which typically includes use of
MMC. The results of this study suggest that the stainless steel
EX-PRESS™ drainage device has similar biocompatibility to
silicone  implants  in  the  eye.  Both  devices  resulted  in
functioning  blebs  of  similar  clinical  characteristics  and
survival time, as well as comparable histological findings. The
presence  of  medical  grade  stainless  does  not  seem  to
negatively  alter  the  healing  response  after  EX-PRESS™
implantation  compared  to  previously  accepted  glaucoma
device materials such as silicone. Further studies are needed
to determine if these results are consistent in humans over
long-term follow up.
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